Literature DB >> 9797530

Remifentanil as an analgesic in the critically ill.

A Main.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9797530     DOI： 10.1046/j.1365-2044.1998.0584a.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN： 0003-2409            Impact factor:   6.955


× No keyword cloud information.
  3 in total

1.  Offset of pharmacodynamic effects and safety of remifentanil in intensive care unit patients with various degrees of renal impairment.

Authors:  Des Breen; Alexander Wilmer; Andrew Bodenham; Vagn Bach; Jan Bonde; Paul Kessler; Sven Albrecht; Soraya Shaikh
Journal:  Crit Care       Date:  2003-11-21       Impact factor: 9.097

2.  Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: a randomized, double-blind controlled trial [ISRCTN43755713].

Authors:  Bernd Muellejans; Angel López; Michael H Cross; César Bonome; Lachlan Morrison; Andrew J T Kirkham
Journal:  Crit Care       Date:  2003-11-20       Impact factor: 9.097

3.  Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial [ISRCTN47583497].

Authors:  Des Breen; Andreas Karabinis; Manu Malbrain; Rex Morais; Sven Albrecht; Inge-Lise Jarnvig; Pauline Parkinson; Andrew J T Kirkham
Journal:  Crit Care       Date:  2005-03-15       Impact factor: 9.097
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.